Kristen Marie Williams serves as Executive at Pacira Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Kristen Marie Williams has executed 84 insider transactions totaling $13.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 14, 2023 involved selling 6,467 shares valued at $239.5K.
Kristen Marie Williams currently holds 25,375 shares of Pacira Pharmaceuticals, Inc. (PCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kristen Marie Williams has been a net seller of PCRX stock. They have purchased $0 and sold $13.1M worth of shares.
Kristen Marie Williams's most recent insider trade was on Jun 14, 2023, when they sold 6,467 shares at $37.03 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Planned |
| Jun 7, 2023 | PCRX | $51.4K | Sale | 1,357 | $37.87 | Discretionary |
| Jun 6, 2023 | PCRX | $50.7K | Sale | 1,301 | $38.99 | Discretionary |
| Jun 8, 2022 | PCRX | $0 | Award | 9,900 | $N/A | Discretionary |
| Jun 7, 2022 | PCRX | $276.7K | Sale | 4,649 | $59.51 | Discretionary |
| Jun 6, 2022 | PCRX | $243.6K | Sale | 3,969 | $61.37 | Discretionary |
| Mar 21, 2022 | PCRX | $527.1K | Sale | 7,253 | $72.67 | Discretionary |
| Mar 21, 2022 | PCRX | $104.3K | Option Exercise | 2,188 | $47.65 | Discretionary |
| Mar 21, 2022 | PCRX | $92.0K | Option Exercise | 2,112 | $43.54 | Discretionary |
| Mar 21, 2022 | PCRX | $113.2K | Option Exercise | 2,953 | $38.35 | Discretionary |
| Feb 25, 2022 | PCRX | $134.1K | Sale | 2,000 | $67.07 | Discretionary |
| Feb 25, 2022 | PCRX | $3.3K | Sale | 50 | $65.00 | Discretionary |
| Feb 25, 2022 | PCRX | $78.6K | Option Exercise | 2,050 | $38.35 | Discretionary |
| Feb 16, 2022 | PCRX | $650 | Sale | 10 | $65.00 | Discretionary |
| Feb 16, 2022 | PCRX | $384 | Option Exercise | 10 | $38.35 | Discretionary |
| Feb 10, 2022 | PCRX | $52.1K | Sale | 800 | $65.18 | Discretionary |
| Feb 10, 2022 | PCRX | $30.7K | Option Exercise | 800 | $38.35 | Discretionary |
| Feb 4, 2022 | PCRX | $65.2K | Sale | 1,000 | $65.18 | Discretionary |
| Feb 4, 2022 | PCRX | $38.4K | Option Exercise | 1,000 | $38.35 | Discretionary |
| Jan 21, 2022 | PCRX | $13.1K | Sale | 200 | $65.41 | Discretionary |
| Jan 21, 2022 | PCRX | $7.7K | Option Exercise | 200 | $38.35 | Discretionary |
| Jan 19, 2022 | PCRX | $144.1K | Sale | 2,199 | $65.51 | Discretionary |
| Jan 19, 2022 | PCRX | $84.3K | Option Exercise | 2,199 | $38.35 | Discretionary |
| Jan 18, 2022 | PCRX | $625.5K | Option Exercise | 13,127 | $47.65 | Discretionary |
| Jan 18, 2022 | PCRX | $60.8K | Option Exercise | 1,375 | $44.20 | Discretionary |
| Jan 18, 2022 | PCRX | $99.7K | Option Exercise | 2,600 | $38.35 | Discretionary |
| Jan 18, 2022 | PCRX | $26.5K | Sale | 400 | $66.14 | Discretionary |
| Jan 18, 2022 | PCRX | $1.5M | Sale | 23,040 | $65.24 | Discretionary |
| Jan 18, 2022 | PCRX | $276.0K | Option Exercise | 6,338 | $43.54 | Discretionary |